Real-Life Experience with Oral Eliglustat in Patients with Gaucher Disease Previously Treated with Enzyme Replacement Therapy.
Article in Journal of Clinical Medicine (October 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
Article in Movement Disorders (December 2018)
Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report
Article in Journal of Medical Case Reports (November 2016)